ClinicalTrials.gg

Program

Sodium Fluoride

Also written as “NaF”, “cetylpyridinium chloride (CPC), zinc lactate and sodium fluoride Mouthwash” and “0.022% Sodium Fluoride mouthwash”.

Its studies are mostly in Gingivitis · Tooth Erosion · Tooth Discoloration · Dental Plaque · Dentin Sensitivity, led by 4 companies.

Furthest: phase 3, since Jul 1, 200816 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
GlaxoSmithKline110 open or runningphase 3since Jul 1, 2008Jul 1, 2008none ahead
Colgate Palmolive30 open or runningphase 3since Jun 27, 2024Jun 27, 2024none ahead
Procter and Gamble10 open or runningphase 2since Mar 19, 2025Mar 19, 2025none ahead
Protegera10 open or runningearly phase 1since Oct 4, 2023Oct 4, 2023none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 1, 2008First studies: 3 phase 3 studiesNew to GlaxoSmithKlineGlaxoSmithKline · NCT00708305, NCT00708123, NCT00708097
  2. Oct 15, 2009Phase 3 study in CariesGlaxoSmithKline · NCT01005966 · 65 enrolled
  3. Apr 30, 2010Phase 2 study in Tooth ErosionGlaxoSmithKline · NCT01128972 · 36 enrolled · United States
  4. Jul 12, 2012Phase 3 study in Enamel ErosionGlaxoSmithKline · NCT01641237 · 72 enrolled · United States
  5. Aug 2, 2012No phase study in Tooth ErosionGlaxoSmithKline · NCT01657903 · 56 enrolled · United States
  6. Jul 17, 2014No phase study in Oral HygieneGlaxoSmithKline · NCT02195583 · 62 enrolled · United States
  7. Jul 21, 20142 phase 2 studies in Oral HygieneGlaxoSmithKline · NCT02207400, NCT02207907
  8. Aug 25, 2014Phase 2 study in Dentin SensitivityGlaxoSmithKline · NCT02226562 · 191 enrolled · United States
  9. Oct 4, 2023Protegera's first study: early phase 1 study in Dental PlaqueNew to ProtegeraProtegera · NCT06082869 · 82 enrolled · United States
  10. Jun 27, 2024Colgate Palmolive's first study: phase 3 study in Tooth DiscolorationNew to Colgate PalmoliveColgate Palmolive · NCT06486974 · 80 enrolled · Dominican Republic
  11. Mar 19, 2025Procter and Gamble's first study: phase 2 study in GingivitisNew to Procter and GambleProcter and Gamble · NCT06892834 · 120 enrolled · Canada
  12. Nov 24, 2025Phase 3 study in GingivitisColgate Palmolive · NCT07263698 · 80 enrolled · Italy
  13. Jan 27, 2026Phase 3 study in Plaque, AmyloidColgate Palmolive · NCT07398846 · 134 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 16 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07398846Plaque, Amyloid · United States3CompletedColgate PalmoliveApr 29, 2026134
NCT07263698Gingivitis · Italy3CompletedColgate PalmoliveFeb 27, 202680
NCT06892834Gingivitis · Canada2CompletedProcter and GambleJun 19, 2025120
NCT06486974Tooth Discoloration · Dominican Republic3CompletedColgate PalmoliveNov 8, 202480
NCT06082869Dental Plaque · United StatesEarly 1CompletedProtegeraFeb 23, 202382
NCT02226562Dentin Sensitivity · United States2CompletedGlaxoSmithKlineDec 1, 2014191
NCT02207907Oral Hygiene · United States2CompletedGlaxoSmithKlineFeb 2015247
NCT02207400Oral Hygiene · United States2CompletedGlaxoSmithKlineFeb 1, 2015246
NCT02195583Oral Hygiene · United States–CompletedGlaxoSmithKlineAug 201462
NCT01657903Tooth Erosion · United States–CompletedGlaxoSmithKlineFeb 201256
NCT01641237Enamel Erosion · United States3CompletedGlaxoSmithKlineMay 201272
NCT01128972Tooth Erosion · United States2CompletedGlaxoSmithKlineOct 200936
NCT01005966Caries3CompletedGlaxoSmithKlineMar 200965
NCT00708305Dental Caries · United States3CompletedGlaxoSmithKlineOct 200865
NCT00708123Healthy Subjects3CompletedGlaxoSmithKlineApr 200860
NCT00708097Caries · United States3CompletedGlaxoSmithKlineJul 200857

How it is read

Names in the registry

  • “NaF”, 2 entries
  • “cetylpyridinium chloride (CPC), zinc lactate and sodium fluoride Mouthwash”, 1 entry
  • “0.022% Sodium Fluoride mouthwash”, 1 entry
  • “Sodium Fluoride Dentifrice”, 1 entry
  • “Protegera™ toothpaste (NaF)”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.